NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ImmunoForge Co., Ltd.

ImmunoForge Co., Ltd.

Private
SeoulHealthcare & Life Scienceshttps://immunoforge.com/

Last Round

Series C

Oct 1, 2025

Est. Valuation

$75.8M

Total Funding Raised

$38.58M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ImmunoForge Co., Ltd. is a biotechnology company that develops therapies for treating cancer and metabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

half-life extensionELP platformrare disease therapeuticsorphan drugsmuscular disease therapeuticslong-acting biologicsdrug licensingdrug delivery platformDuchenne muscular dystrophyDMDclinical stage biopharmapeptide therapeuticsprotein therapeuticssustained release deliveryOrphan Drug DesignationODDblood-brain barrier shuttleGLP-1R agonist

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ImmunoForge Co., Ltd. Comparables

Compare ImmunoForge Co., Ltd. with similar companies based on industry and business-model similarity.

ImmunoForge Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
XL-protein
76%
Hanmi Pharm Co Ltd
74%
Sanofi
71%

ImmunoForge Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series COct 1, 2025
Series BSep 1, 2021
Series A ExtensionAug 1, 2020
Series AFeb 1, 2019
SeedDec 1, 2017

ImmunoForge Co., Ltd. Investors

Notable investors and investment history

ImmunoForge Co., Ltd. investors
InvestorRounds
BNH INVESTMENTSeries B, Series A
Smilegate InvestmentSeries A
Company K PartnersSeries C, Series B, Series A
KB SecuritiesSeries B
Kiwoom InvestmentSeries B
Korea Omega Investment CorpSeries A
Korea Development BankSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2025

    Raised $9.5M from Company K Partners, LB Investment, and Korea Development Bank.

  • Sep 1, 2021

    $19M round with participation from KB Securities and Kiwoom Investment.

ImmunoForge Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ImmunoForge Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ImmunoForge Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range1
Year Founded2017
Last FundingOct 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.